latest articles

Multiband Offers $22.7M to Buy PA Company

If a merger agreement is reached, Multiband said that the acquisition of Pennsylvania-based WPCS International would add more than $100 million in revenue and between $5 million and $8 million in earnings annually.

Welsh Companies to Join Colliers International

Starting August 1, Welsh Companies' brokerage and property management divisions will begin operating under the Colliers International organization-marking Colliers' reentrance into the Twin Cities market.

Which MN Housing Markets Are Most and Least Expensive?

According to a new real estate report, Red Wing is the most expensive Minnesota housing market, and Owatonna is the least expensive; with an average listing price of $329,782 for a four-bedroom, two-bathroom home, St. Louis Park is the most-expensive market within the Twin Cities metro area.

Commercial Real Estate Pros. More Optimistic

A recent survey of 50 local real estate professionals showed signs of optimism about the commercial real estate market during the next two years, despite an anticipated increase in land prices and building materials.

Dayton Releases Shutdown Plan for MN Agencies

Governor Dayton released his recommendations about which state agencies should continue offering services with limited staff during a government shutdown; MnSCU was spared, but many others were not.

MN Cos. Affected as J&J Exits Stent Market

As Johnson & Johnson prepares to stop manufacturing drug-coated stents, competitors like Medtronic and Boston Scientific could see a boost in sales. Surmodics, however, a supplier to Johnson & Johnson, said that it is "disappointed" with the news.

MN Med-Tech Cos. Dispute New Heart Device Study

Roughly 40 percent of patients implanted with cardiac resynchronization therapy devices may not reap benefits from the expensive treatment, according to a new study. But med-tech giants Medtronic and St. Jude disagree, stating that current guidelines for using the devices were established through credible clinical trials.